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TrimethylationonhistoneH3 lysine27 (H3K27me3)by
Polycomb repressive complex 2 (PRC2) regulates
the balance between self-renewal and differentiation
of embryonic stem cells (ESCs). The mechanisms
controlling the activity and recruitment of PRC2
are largely unknown. Here we demonstrate that
the founding member of the Jumonji family, JMJ
(JUMONJI or JARID2), is associated with PRC2,
colocalizes with PRC2 and H3K27me3 on chromatin,
and modulates PRC2 function. In vitro JMJ inhibits
PRC2 methyltransferase activity, consistent with
increased H3K27me3 marks at PRC2 targets in
Jmj/ ESCs. Paradoxically, JMJ is required for effi-
cient binding of PRC2, indicating that the interplay
of PRC2 and JMJ fine-tunes deposition of the
H3K27me3 mark. During differentiation, activation
of genes marked by H3K27me3 and lineage commit-
ments are delayed in Jmj/ ESCs. Our results
demonstrate that dynamic regulation of Polycomb
complex activity orchestrated by JMJ balances self-
renewal and differentiation, highlighting the involve-
ment of chromatin dynamics in cell-fate transitions.
INTRODUCTION
Eukaryotic gene transcription is influenced by chromatin struc-
ture, in large part established through modification of histone tails
(Kouzarides, 2007). Methylation of lysine residues in histones is
dynamically regulated by the opposing activities of histone lysine
methyltransferases (KMTs) and demethylases (KDMs) (Cloos
et al., 2008). Recently several KDMs with exquisite substrate
specificity have been implicated in diverse processes, including
embryonic patterning, stem cell self-renewal, differentiation,Cneuronal development, and spermatogenesis (Nottke et al.,
2009). Mutations or deregulation of KDMs are often linked to
human cancers and diseases (van Haaften et al., 2009; Yamane
et al., 2007).
The majority of KDMs are characterized by the presence of
a JmjC domain, a conserved region first recognized in the
founding member of the Jumonji family, JUMONJI (JMJ or
JARID2). A catalytic triad (H, D/E, H), which is predicted to
mediate cofactor Fe(II) binding, is highly conserved in JmjC-
containing proteins and required for KDM activity (Klose and
Zhang, 2007). JMJ, however, has amino acid substitutions in
this subregion and is predicted to be enzymatically inactive
(Cloos et al., 2008). Nonetheless, JMJ is critical in embryonic
development. Jmj/ mouse embryos develop various defects
in neuronal, cardiac, liver, and hematopoietic tissues with pene-
trance dependent on the genetic background (Jung et al., 2005;
Takeuchi et al., 2006). Developmental defects have been asso-
ciated with increased numbers of progenitor cells and depletion
of differentiating or mature cells, suggesting a role for JMJ in
regulating proliferation and differentiation. Despite the activities
of JMJ-related proteins in chromatin regulation and the multiple
roles of JMJ in development, the function of JMJ is poorly
understood.
Polycomb group (PcG) proteins are required for establishing
and maintaining cellular memory. Four PcG proteins, including
two EZH proteins (EZH1/EZH2), EED, and SUZ12, comprise
the core of the Polycomb repressive complex 2 (PRC2), a
methyltransferase complex that acts specifically on histone H3
lysine 27 (H3K27) (Margueron et al., 2008; Shen et al., 2008). In
embryonic stem cells (ESCs), PRC2 is critically required for
both maintenance and execution of pluripotency (Boyer et al.,
2006; Pasini et al., 2007; Shen et al., 2008). PRC2 and trimethy-
lation on H3K27 (H3K27me3) occupy a set of genes controlling
differentiation and prevent full expression of these genes until
lineage commitment. Despite its central role in development,
little is known regarding how the activity of PRC2 is regulated,
PRC2 is targeted to distinct regions during cell fate transitions,ell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc. 1303
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Figure 1. JMJ Interacts with the PRC2
Complex
(A) The scheme to identify PRC2-interacting
proteins.
(B) A PRC2 interactome. Proteins highlighted in
yellow are tagged baits for affinity purification.
Solid and dotted lines indicate interactions identi-
fied by multiple or few replicates, respectively. The
interaction between BCLAF1 and THRAP3 was
reported previously (Bracken et al., 2008).
(C–E) Coimmunoprecipitation (coIP) analysis in
293T cells. V5-tagged MTF2, HA-tagged JMJ,
bfEED, and bfEZH2 were coexpressed (C). V5-
MTF2 (D) or HA-JMJ (E) was coexpressed with
bfEED, bfEZH1, or bfEZH2 as indicated.
(F) Gel-filtration analysis of nuclear extracts from
CJ7 ESCs. Migration of molecular markers is indi-
cated above the panels, and the antibodies for
western blotting are shown on the left.
(G) Streptavidin (SA)-mediated coIP in ESCs
expressing birA alone, bfEED, bfEZH2, or mutant
EZH2 with SET domain deleted (bfEZH2 dSET).
bfEZH2 dSET is indicated by *.
(H) Anti-SUZ12 coIP in Jmfl/fl and Jmj/ ESCs.
(I and J) Anti-JMJ antibody-mediated coIP in ESCs
and non-pluripotent cells.
In (C)–(J), ‘‘I’’ indicates inputs and ‘‘P’’ indicates
coIP fractions. About 5% of nuclear extracts
used for coIP were loaded as the inputs.or the pluripotent state is maintained to preserve plasticity, such
that the influence of the H3K27me3 mark may be attenuated
when gene expression is required.
To address these issues, we characterized the PRC2 complex
in mouse ESCs and identified closely associated proteins in
a PRC2 interactome. Here we demonstrate that JMJ is a subunit
of the PRC2 complex, colocalizes with PRC2 on chromatin, and
regulates H3K27me3 modification by modulating PRC2 activity.
Fine-tuned, dynamic regulation of H3K27me3 by JMJ and PRC2
balances the stem cell state and differentiation.
RESULTS
JMJ Interacts with PRC2
To identify proteins associated with PRC2, we affinity-purified
the complex using a previously described in vivo biotinylation
strategy (Wang et al., 2006). Nuclear extracts from ESCs coex-
pressing bacterial biotin ligase (BirA) and subendogenous1304 Cell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc.levels of biotin- and FLAG-tagged EED,
EZH1, or EZH2 referred to as bfEED,
bfEZH1, or bfEZH2 (Shen et al., 2008)
were subjected to streptavidin-mediated
coimmunoprecipitation or tandem coim-
munoprecipitation mediated by anti-
FLAG antibody and streptavidin. Interact-
ing proteins were then identified by mass
spectrometry sequencing (Figure 1A;
Tables S1–S4 available online).
In addition to known PRC2 core com-
ponents including EZH1/EZH2, EED,SUZ12, RBBP4, and AEBP2, we identified several interacting
partners of PRC2 including JUMONJI (JMJ), metal response
element-binding transcription factor 2 (MTF2), and serine/threo-
nine kinase 38 (STK38). To confirm the putative interacting
proteins and to expand the PRC2 interaction network, we then
tagged MTF2 and JMJ with a biotin tag and FLAG epitope (herein
referred to as bfMTF2 and bfJMJ) in ESCs. The reverse tagging
analysis confirmed association of PRC2 with MTF2 and JMJ
(Tables S5 and S6). We did not detect peptides representing
the H3K9 methyltransferases G9a and GLP that were reported
to interact with JMJ when overexpressed in NIH 3T3 cells (Shir-
ato et al., 2009).
Based on proteomic results, we constructed an ‘‘interactome’’
surrounding PRC2 (Figure 1B), which includes the core PRC2
components, MTF2, JMJ, STK38, RBBP7, and additional JMJ-
interacting proteins that may indirectly or transiently associate
with PRC2. Interestingly, bfJMJ pulled down few peptides repre-
senting MTF2, and bfMTF2 did not capture JMJ (Table S1). Thus,
these two PRC2-associated proteins may not coexist in the
same PRC2 complex. To validate the above interactions, we
coexpressed V5-tagged MTF2, HA-tagged JMJ, bfEED, and
bfEZH2 in 293T cells. Coimmunoprecipitation of MTF2, JMJ,
or EED/EZH2 pulled down the other three components (Fig-
ure 1C), suggesting their coexistence in one protein complex.
To verify binary interactions, we coexpressed V5-tagged MTF2
or HA-tagged JMJ with one of bfEED, bfEZH,1 and bfEZH2 in
293T cells. Both MTF2 and JMJ bind to EED, EZH1, or EZH2
(Figures 1D and 1E).
MTF2 (also called PCL2) is a member of the Polycomblike/
PHF1 (PCL1) family proteins, which associate with PRC2 in fly
and in mammal (Cao et al., 2008; Nekrasov et al., 2007; Sarma
et al., 2008; Savla et al., 2008). Because of the recognized impor-
tance of Jumonji family proteins in regulating chromatin struc-
ture, cellular function, and development (Cloos et al., 2008;
Nottke et al., 2009), we focused on the interaction of JMJ with
PRC2. Fractionation of nuclear extracts from CJ7 ESCs by gel
filtration shows that JMJ comigrates with EZH2 with two peaks
centered at 3908 kDa and 395 kDa (Figure 1F), indicating that
JMJ is possibly associated with a fraction of PRC2 in ESCs.
Streptavidin capture of bfEZH2 and bfEED in ESCs precipitates
endogenous JMJ (Figure 1G). An anti-SUZ12 antibody mediates
coimmunoprecipitation of JMJ but not RBP2, the H3K4 deme-
thylase, in wild-type ESCs (Figures 1H and S1). Reciprocal coim-
munoprecipitation mediated by an anti-JMJ antibody captures
endogenous EZH2, EED, and SUZ12 (Figures 1I and 1J). These
results demonstrate that JMJ interacts with PRC2 in a physiolog-
ical setting.
In Ezh2/ mutant ESCs, JMJ fails to coimmunoprecipitate
with EED and captures significantly less SUZ12 compared to
that in wild-type cells (Figure 1I). In addition, an EZH2 mutant
lacking the catalytic SET domain (bfEZH2 dSET) (Shen et al.,
2008) coimmunoprecipitates with SUZ12 but not JMJ
(Figure 1G). These results implicate EZH2 and its SET domain
in mediating in vivo association of JMJ and PRC2. EED appears
dispensable for this interaction as JMJ coimmunoprecipitates
with EZH2 and SUZ12 in Eed/ ESCs. Endogenous JMJ pulls
down PRC2 not only in ESCs but also in mouse erythroleukemia
(MEL) cells and F9 embryonic carcinoma cells (Figure 1J). There-
fore, the interaction between JMJ and PRC2 is not unique to
pluripotent ESCs.
JMJ Colocalizes with PRC2 on Chromatin
JMJ contains a conserved ARID/BRIGHT domain, which can
bind DNA (Kim et al., 2003). We sought to identify DNA targets
of JMJ. Chromatin immunoprecipitation (ChIP) in ESCs using
antibody to JMJ shows that endogenous JMJ is significantly
enriched at promoters of PRC2 target genes (Figure 2A). To iden-
tify gene targets of JMJ in a global fashion, we performed ChIP-
chip on Affymetrix promoter tiling arrays. Out of 644 target genes
bound by JMJ (Figure 2B; Tables S7, S8, and S13), 632 (98%)
genes overlap with genes marked by H3K27me3 (Shen et al.,
2008). Moreover, 81%–98% of JMJ target genes overlap with
targets of EZH2, SUZ12, and bfEED (Figure 2C; Tables S7A
and S10–S13). The extent of overlap between JMJ and PRC2/
H3K27me3 targets greatly exceeds the reported colocalization
between RBP2 and H3K27me3, in which only 195 out of 606CRBP2 target genes overlap with H3K27me3 targets (Pasini
et al., 2008).
Results with the conventional ChIP method are highly
dependent on the quality of available antibodies to the target
protein, whereas bioChIP obviates the need for antibodies and
takes advantage of the strong interaction between biotin and
streptavidin (Kim et al., 2008; Shen et al., 2008). To refine the
genome-wide targets of JMJ, we analyzed ESCs expressing sub-
endogenous level of bfJMJ (data not shown) and confirmed the
enrichment of bfJMJ on PRC2 targets (Figure 2D). BioChIP-
chip of bfJMJ on Affymetrix whole-genome tiling arrays revealed
many more targets (3695 genes) than JMJ antibody-mediated
ChIP-chip (Figure 2B and Table S9). As 97% of JMJ ChIP-chip
targets overlap bioChIP-chip targets (Table S7), bioChIP-chip
faithfully maps comprehensive coverage of chromatin binding
of endogenous JMJ. Over 80% of H3K27me3, bfEZH1, or
bfEZH2 targets overlap those of bfJMJ (Table S7), confirming
genome-wide colocalization of JMJ with PRC2 and H3K27me3.
JMJ occupies genomic regions in close proximity to transcription
start sites (TSS) (Figure 2E). Similar to H3K27me3 target genes,
JMJ target genes are enriched in development-related functions
(Figure 2F). Thus, JMJ interacts with PRC2 at both protein and
chromatin levels.
JMJ-Containing Protein Complex Shows
Methyltransferase Activity on H3K27
To address functional implication of the interaction of JMJ with
PRC2, we assayed JMJ-associated proteins for KMT activity.
Indeed, proteins that coprecipitate with bfJMJ in ESCs demon-
strate KMT activity toward core histones in a dose-dependent
manner similar to the bfEZH2-containing complex captured by
streptavidin (Figure 3A). In addition, the endogenous JMJ-con-
taining complex precipitated by an anti-JMJ antibody shows
KMT activity toward nucleosomes, which are the natural
substrates in vivo (Figure 3B).
To study substrate specificity, recombinant histones bearing
methyl lysine analogs (MLAs) were used to examine desired
methylation patterns on histone H3. These MLAs (indicated as
Kc) behave similarly to their natural counterparts (Simon et al.,
2007). The bfEZH2-containing complex shows decreasing
activity on the H3 substrates with increasing numbers of methyl
groups on residue 27 (Figure 3C). This result is consistent with
the report that monomethylation activity of PRC2 is dominant
to its trimethylation activities in vitro (Sarma et al., 2008). A
weak methylation signal observed on H3Kc27me3, which
contains saturated methyl groups, may reflect nonspecific
activity of PRC2 on lysine 9 in vitro. Although PRC2 specifically
acts on H3K27 in vivo, recombinant human PRC2 exhibits
weak KMT activity on H3K9 in vitro (Kuzmichev et al., 2002).
The bfJMJ complex exhibits substrate specificity similar to
that of the bfEZH2 complex with the highest and lowest activity
toward unmethylated H3 and H3Kc27me3, respectively, sup-
porting the physical existence of JMJ and PRC2 in one protein
complex. Moreover, the endogenous JMJ-containing complex
shows similar activity on unmethylated H3 and H3Kc9me3
substrates but significantly weaker activity on the H3Kc27me3
substrate (Figure 3D), implying that the JMJ-PRC2 complex
specifically acts on H3K27 but not H3K9.ell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc. 1305
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Figure 2. JMJ Colocalizes with the PRC2
and H3K27me3 Mark on Chromatin
(A) ChIP-qPCR analysis in ESCs. The Actb
promoter and an intergenic region (Cs) serve as
negative controls. Error bars represent standard
deviations of relative enrichments to inputs.
(B) Venn diagram of genome-wide colocalization
of JMJ, bfJMJ, and the H3K27me3 mark.
(C) Representative view of ChIP-chip peaks at
various genomic loci in the Affymetrix Integrated
Genome Browser. Arrows indicate transcription
start and direction. Unless indicated by ‘‘mmP’’
(Affymetrix mouse promoter tiling array), chip
hybridization was performed on mouse whole-
genome tiling array sets.
(D) BioChIP-qPCR analysis in ESCs expressing
birA control only, bfJMJ, or bfEZH2. Error bars
represent standard deviations of relative enrich-
ments to inputs.
(E) ChIP-chip signals around transcription start
sites (TSS). Average enrichment ratios within ±
10 kb regions relative to TSS were calculated
based on MAT scores.
(F) Gene ontology (GO) analysis of H3K27me3
target genes (p < 1e-5).JMJ Inhibits PRC2 Activity In Vitro
Mammalian JMJ contains several conserved motifs including
JmjN, ARID/BRIGHT, JmjC, and C5HC2 zinc finger domains
(Figure S2). Mutation of the critical residues involved in cofactor
binding in the JmjC domain predicts that JMJ is inactive as a de-
methylase, a function distinguishing many Jumonji family
members (Cloos et al., 2008). Consistent with the prediction,
we failed to detect KDM activity of JMJ regardless of the pres-
ence of EZH2 (Figure S3). Moreover, addition of JMJ had no
obvious effect on known KDMs (Figure S3).
To ask whether JMJ assembles as a stoichiometric compo-
nent of PRC2, we reconstituted JMJ-PRC2 through baculoviral
expression. Anti-HA coimmunoprecipitation targeted to EED
captures JMJ, which is present at 1/4 the amount of EZH2.
Therefore, JMJ is a substoichiometric component of PRC2 (Fig-
ure 4A). This result suggests that PRC2 may exist in two forms:
JMJ-containing and JMJ-free PRC2 complexes.1306 Cell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc.A chromatin fraction mainly comprised
of oligonucleosomes from HeLa cells
contains endogenous KMT activity (Fig-
ure 4B). Addition of increasing amounts
of JMJ but not bovine serum albumin
(BSA) markedly inhibits this activity.
Close interaction between JMJ and
PRC2 suggests that JMJ may directly
regulate the KMT activity of PRC2. To
test this possibility, we reconstituted
KMT reactions with recombinant PRC2
and histone H3 MLAs with the defined
methylation pattern at residues Kc27
and Kc9.
Addition of JMJ did not affect PRC2-
mediated monomethylation on H3 andH3Kc9me3 substrates (Figure 4C). JMJ dramatically downmo-
dulates PRC2 activity on H3Kc27me1 and me2 substrates in
a dose-dependent manner (Figure 4C). BSA has no effect on
PRC2, indicating the specificity of the assay. JMJ failed to inhibit
PRC2 on chicken core histones (data not shown), presumably
due to dominant monomethylation catalyzed by PRC2 in vitro,
which may mask the inhibitory effect of JMJ on di- and trimethy-
lation. The JMJ mutant (dJc) lacking the C-terminal JmjC and
C5HC2 domains also inhibits di- and trimethylation activity of
PRC2 (Figure 4D), suggesting that the JmjC and C5HC2 domains
are dispensable for JMJ activity on PRC2.
To test whether JMJ specifically inhibits PRC2 activity on more
physiological substrates, we assembled recombinant histone
octamers and nucleosomes containing H3Kc27me0, me1, or
me2. Consistent with histone substrates, JMJ inhibited PRC2-
mediated di- and trimethylation in a dose-dependent manner
on MLA octamers and nucleosomes (Figures 4E and 4F). JMJ
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Figure 3. Histone Methyltransferase Assays Show Intrinsic KMT
Activity within the JMJ-Containing Complex
(A) Addition of increasing amounts of the JMJ-containing complex captured by
streptavidin (SA)-mediated coIP from ESCs expressing bfJMJ exhibits
increasing KMT activity on chicken core histones. BirA and bfEZH2 serve as
the negative and positive controls, respectively.
(B) Proteins captured by anti-JMJ and anti-SUZ12 antibodies show KMT
activity toward nucleosomes from HeLa cells. Nucleosomes were pretreated
at 50C for 10 min to inactivate copurified, endogenous KMTs.
(C) KMT activity of bfJMJ and bfEZH2 complexes on recombinant histone H3
substrates. The bottom panel shows western blotting of EZH2 to ensure equal
addition of coIPed protein complexes.
(D) KMT activity of endogenous JMJ protein complex captured by an anti-JMJ
antibody on recombinant histone H3 substrates.
The lower panels in (A), (B), and (D) and the middle panel in (C) are protein gels
stained by Colloidal blue to show equal addition of substrates.also inhibited monomethylation activity of PRC2 on H3Kc27me0
octamers and nucleosomes, indicating that JMJ-PRC2 may
exhibit different enzymatic activities toward H3 histone,
octamers, core histones (which contain octamers plus the linker
histone H1), and nucleosomal substrates in vitro. Nevertheless,
these results demonstrate that JMJ inhibits di- and trimethyla-
tion activity of PRC2.
JMJ Fine-Tunes the H3K27me3 Level In Vivo
To investigate how JMJ regulates PRC2 function in vivo, we iso-
lated Jmj conditional knockout (fl/fl) ESCs. Deletion of exon 3
creates a frameshift and subsequent termination mutation (Fig-
ure S2A), resulting in a mutant peptide of 15 amino acids that
contains none of the known functional motifs of JMJ (Mysliwiec
et al., 2006). By Cre recombinase-mediated excision of the fl
alleles in vitro, we established Jmj/ ESCs, in which JMJ
expression is completely abolished and JMJ is no longer
detected at PRC2 target loci by ChIP (Figures 5A–5C). Anti-
SUZ12 coimmunoprecipitation in Jmj/ cells fails to detect
a protein band representing JMJ (Figure 1H), confirming the
specificity of the interaction between JMJ and PRC2. Jmj/
ESCs show normal expression of pluripotency markers (Table
S14) and proliferate at a rate similar to wild-type ESCs under
standard conditions (data not shown). Thus, JMJ is dispensable
for ESC self-renewal and maintenance.CAs JMJ inhibits PRC2 trimethyltransferase activity in vitro, we
investigated whether loss of JMJ affects H3K27me3 levels
in vivo. Global levels of H3K27 methylation, as well as other
histone marks, are not affected in Jmj/ ESCs (Figure S4),
consistent with a role of JMJ as a modifier of PRC2. However,
moderate, but consistent, enhancement of H3K27me3 binding
at individual PRC2 target loci is observed in Jmj/ cells
(Figure 5D).
To study the effect of Jmj loss on gene expression of PRC2
and H3K27me3 targets, we performed microarray profiling of
Jmj/ and Jmjfl/fl ESCs (Table S14). By Gene Set Enrichment
Analysis (GSEA), we ranked genes from high to low based on
the correlation between their expression levels in these two
cell types (Figure 5E). Genes that are upregulated in Jmj/
ESCs compared to Jmjfl/fl ESCs are ranked at the top of the
list, whereas genes that are downregulated are ranked toward
the bottom of the list. We previously identified a subset of
H3K27me3 target genes referred to as ‘‘H3K27me3-(WT)-Day6
UP’’ genes that are repressed in undifferentiated ESCs but upre-
gulated at day 6 of ESC differentiation (Shen et al., 2008). We
then asked where members of this H3K27me3 target gene set
are distributed in the ranked dataset. We find that H3K27me3
target genes distribute toward the bottom of the rank list with
a significant normalized enrichment score (NES) of 2.9 (Fig-
ure 5E), indicating reduced expression in Jmj/ ESCs. Thus,
accentuated repression of H3K27me3 genes is consistent
with ChIP analysis, indicating that increased presence of
H3K27me3 on chromatin may further repress PRC2 targets
that normally exhibit low levels of transcription.
The enrichment of JMJ at PRC2 targets is markedly reduced in
Ezh2/ and Eed/ ESCs (Figure 5C), indicating a requirement
of EZH2 and EED in targeting JMJ to chromatin. This result is
consistent with the observation that JMJ lacks specific binding
affinity to methylated histones, as revealed by histone peptide
binding assays (Figure S5). On the other hand, enrichment of
SUZ12, EZH2, and EED at PRC2 targets is significantly
decreased in Jmj/ ESCs (Figures 5F–5H), pointing to a positive
role of JMJ in facilitating PRC2 binding to chromatin. Thus, JMJ
modulates PRC2 function in opposing ways. As PRC2 and UTX/
JMJD3 function as KMTs and KDMs, respectively, to control
‘‘on’’ and ‘‘off’’ switches of H3K27me3, JMJ functions as a modi-
fier of PRC2 to fine-tune the level of H3K27me3 by promoting
chromatin binding, while also inhibiting the KMT activity of
PRC2 (Figure 5I).
JMJ Is Required for Proper ESC Differentiation
The core components of PRC2 including EZH2, EED, and SUZ12
appear to be more important in executing than in maintaining
pluripotency (Pasini et al., 2007; Shen et al., 2008). To investigate
the role of JMJ in regulating ESC pluripotency, we differentiated
Jmj/ and Jmjfl/fl ESCs by withdrawal of leukemia inhibitory
factor (LIF) and performed microarray expression profiling.
Global gene expression in Jmj/ ESCs was compared to that
in Jmjfl/fl ESCs by GSEA. H3K27me3 targets are distributed
primarily toward the bottom of the ranked list in their enrichment
profiles with the lowest NES of 3.0 at day 4 compared to 2.5
and 2.0 at days 6 and 8 of differentiation, respectively
(Figure 6A). Consistent with GSEA, which provides a statisticalell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc. 1307
B D
A C
H3 loading
H-methyl3
K27me0 Kc27me1   Kc27me2     Kc9me3     Kc27me1substrates:
PRC2
JMJ
EZH2 / SUZ12
EED / RBBP4
AEBP2
(-) (-)
H-methyl3
EZH2 / SUZ12
EED / RBBP4
AEBP2
     H3 loading
JMJ    dJc
 J
M
J
(-)
(-)
 Kc27me1        Kc27me2H3 substrates:
dJ
c
E
JMJ
   EZH2
 SUZ12
    EED
RBBP4
AEBP2
H-methyl3
Nucleosome
    loading
0
0.2
0.4
0.6
0.8
1
Kc27me0    Kc27me1    Kc27me2    
H-methyl3
 loading
JMJ
EZH2 / SUZ12
EED / RBBP4
AEBP2
Kc27me0        Kc27me1       Kc27me2    
* *
F
JMJ
Figure 4. JMJ Inhibits Methyltransferase
Activity of PRC2
(A) Reconstitution of JMJ with PRC2 in vitro.
Except for the first lane in which JMJ-expressing
baculovirus is omitted, FLAG-tagged JMJ was
coexpressed with FLAG-tagged EZH2, HA-tagged
EED, SUZ12, RBBP4, and AEBP2 in Sf21 cells.
Captured proteins were separated on the gel and
stained by Colloidal blue. While equal amounts of
JMJ and EZH2 were captured by anti-FLAG anti-
body, JMJ captured with HA-EED is 1/4 the
amount of EZH2, indicating JMJ as a substoichio-
metric component of PRC2.
(B) JMJ inhibits intrinsic methyltransferase activity
associated with crude nucleosomes purified from
HeLa cells. The top plot shows the quantification
of the autoradiography (in the middle). The lower
panel shows equal loading of nucleosomes (5 mg).
About 0.5–2 mg of JMJ and 4–10 mg of bovine
serum albumin (BSA) were added as indicated.
(C) JMJ inhibits di- and trimethyltransferase activ-
ities of PRC2 on recombinant histones (1 mg per
reaction). About 2–10 mg of BSA (indicated by #)
was added as indicated.
(D) The JmjC and C5HC2 domains of JMJ are
dispensable for the inhibitory function of JMJ on
PRC2. The protein band corresponding to the
JMJ mutant (dJc) is indicated by *.
(E and F) JMJ inhibits all methylation activities of
PRC2 on MLA octamers (E) and nucleosomes (F).
About 2 mg of BSA was added.
In (C)–(F), 5 mg of PRC2 and 0.5–2 mg of JMJ or dJc
were added as indicated. The upper panels show
autoradiography. The middle and bottom panels
are protein gels stained by Colloidal blue to show
additions of substrates and enzymes, respectively.comparison of a previously defined gene set between two
cell types, heatmap analysis shows that the activation of
H3K27me3 target genes in Jmj/ ESCs is delayed and not acti-
vated to the same extent as in Jmjfl/fl cells during differentiation
(Figure 6B).
Upon LIF withdrawal pluripotent ESCs differentiate into three
germ layers including neuroectoderm, mesoderm, and endo-
derm. Mesoendoderm (ME) is a transient cell state prior to further
differentiation into mesoderm and endoderm. Both JMJ and
H3K27me3 occupy a set of genes critical for development.
We studied the effect of JMJ loss on lineage differentiation,
particularly genes enriched in neural progenitors (NP) and
mesoendodermal (ME) lineages, which were previously defined
as ‘‘NP-high’’ genes and ‘‘ME-high’’ genes, respectively (Shen
et al., 2008).
GSEA and heatmap analysis indicate significant underrepre-
sentation of NP-high genes in Jmj/ cells during differentiation
(Figures 6A and 6B). ME-high genes in Jmj/ cells are also
significantly downregulated at day 4 and day 6 of differentiation
but eventually become overrepresented with a positive NES of
1.7 at day 8 of differentiation (Figures 6A and 6B). Thus, loss
of JMJ results in compromised and delayed differentiation of1308 Cell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc.ESCs. Imposition of excessive H3K27me3 marks in the absence
of JMJ may render a less permissive chromatin conformation on
target genes and attenuate rapid reconfiguration of chromatin
states in response to differentiation signals.
To confirm microarray analysis, we analyzed expression of
marker genes in wild-type (Jmjfl/fl) and polycomb mutant ESCs
including Jmj/,Ezh2/, and Eed/ cells (Figure 6C). Jmj tran-
scripts are downregulated 6-fold and 8-fold, respectively, at day
4 and day 8 of differentiation, implying early involvement of JMJ
in regulation of ESC differentiation. Upon differentiation higher
expression of ESC-specific genes, including the pluripotency
marker Oct4, is observed in Jmj/ cells as compared to Jmjfl/fl
cells (Figures 6C and S6). Delayed attenuation of pluripotency
genes confirms a delay in differentiation.
Fgf5 is a marker for primitive ectoderm, a transient cell state
that pluripotent ESCs must proceed through before differenti-
ating to three germ layers. In wild-type ESCs, the expression of
Fgf5 reaches its peak at day 2 of differentiation and is gradually
downregulated thereafter (Figure 6C). This pattern of expression
is consistent with a transitory existence of primitive ectoderm
during development. However, Ezh2/ and Eed/ cells show
abnormal activation of Fgf5 at day 2 but an abrupt drop to
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Figure 5. Characterization of Jmj/ ESCs
(A) Reverse transcription (RT) and qPCR analysis
of Jmj transcripts in wild-type and mutant ESCs.
Error bars are standard deviations of relative
expression to GADPH.
(B) Western blotting analysis of wild-type and
mutant ESCs.
(C) ChIP-qPCR analysis of JMJ in wild-type (WT)
and mutant ESCs.
(D) ChIP-qPCR analysis of the H3K27me3 mark in
Jmj/ and wild-type ESCs. * indicates p < 0.05 by
a Student’s paired t test with a two-tailed distribu-
tion.
(E) GSEA profile of the set of H3K27me3 target
genes. Genes are ranked into an ordered list based
on the correlation between their expression levels
in Jmj/ and Jmjfl/fl ESCs. Genes that are upregu-
lated in Jmj/ESCs are ranked at the top of the list
(left, red), whereas downregulated genes are
ranked toward the bottom (right, blue). The middle
portion of the plot shows where the members of the
gene set (indicated by vertical lines) locate in the
ranked list shown in the bottom portion. The green
curve in the top portion shows the running enrich-
ment score (ES) for the gene set as the analysis
walks down the ranked list. The distribution of
H3K27me3 target genes appear toward the bottom
of the rank list with a normalized enrichment score
(NES) of2.9. Statistic significance is indicated by
nominal p value, familywise-error rate (FWER), and
false discovery rate (FDR).
(F–H) ChIP-qPCR analysis of EZH2 (F), SUZ12 (G),
and EED (H) at PRC2 targets in wild-type and
mutant ESCs.
In (C), (D), and (F)–(H), error bars are standard devi-
ations of relative enrichments based on at least
three biological repeats. The Actb promoter and
an intergenic region (Cs) serve as negative controls.
(I) A model shows dynamic regulation of H3K27me3. PRC2, the H3K27 methyltransferase complex (KMT), and UTX and JMJD3, the H3K27me3 demethylases
(KDM), represent on-off controls on H3K27me3. While PRC2 catalyzes the formation of H3K27me3, UTX and JMJD3 demethylate H3K27me3. In contrast to
KMTs and KDMs, JMJ, as a modifier of PRC2, fine-tunes the levels of H3K27me3 by regulating the activity and recruitment of PRC2.a significantly lower level at day 4, suggesting rapid entrance into
and exit from the primitive ectoderm state. Despite normal acti-
vation at day 2 in Jmj/ cells, Fgf5 expression progressively
rises to nearly 8-fold higher than that in wild-type cells at
day 6. Persistent, high-level expression of Fgf5 suggests that
Jmj/ cells differentiate into primitive ectoderm but further
development is stalled at this stage.
Consistent with prolongation of the primitive ectodermal state,
Jmj/ cells show delayed commitment to the three somatic line-
ages (Figure 6C). For example, neuronal gene Sox11 fails to be
upregulated upon differentiation in mutant cells. Brachyury (T),
an early marker for mesoendoderm, reaches its peak expression
at day 4 in wild-type cells. However, Jmj/ cells weakly express
T at day 4 and show peak activation at day 6, at a time when
T expression in wild-type cells has already been downregulated.
Additional mesoderm markers, such as Sp5, Bmp4, and Hoxa1,
also show delayed and compromised activation. In Ezh2/ and
Eed/ cells, both T and Sp5 show a time course of activation
similar to that of wild-type ESCs, but the extent of activation is
reduced, reflecting induction but failure to sustain mesoendo-
derm in these mutant cells.CExpression of CD44, a cell-surface marker in mesenchymal
stem cells important for epithelial-mesenchymal transition
(EMT), is not activated appropriately in Jmj/ cells (Figure 6C).
In contrast, CD44 expression is activated but not sustained in
Ezh2/ and Eed/ cells. Lastly, cell-cycle regulators, including
cyclin D2 (Ccnd2) and Cdkn2a (p16), which are highly expressed
in all three germ layers, are expressed at abnormally high levels
in Ezh2/ and Eed/ cells, suggesting that differentiation may
be initiated but cannot be sustained due to cell-cycle arrest. In
contrast, Ccnd2 and Cdkn2a are not activated until day 8 of
differentiation in Jmj/ cells with expression levels significantly
lower that those in Jmjfl/fl cells (Figure 6C). Therefore, global and
individual gene analysis demonstrate that Jmj/ ESCs fail to
respond to differentiation signals promptly and exhibit delayed,
compromised lineage commitment.
DISCUSSION
We have identified JMJ as an associated protein of the PRC2
complex. JMJ colocalizes with PRC2 and the H3K27me3 mark
in chromatin. The endogenous JMJ-containing complex exhibitsell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc. 1309
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Figure 6. Jmj Is Required for ESC Differentiation
(A) GSEA profiles of the sets of H3K27me3 target genes, NP-high (enriched in neural progenitors) and ME-high genes (enriched in mesoendodermal lineage).
(B) Heatmaps show expression of genes in three gene sets indicated in (A) in Jmjfl/fl and Jmj/ cells during ESC differentiation.
(C) Time-course analysis of marker genes during differentiation by RT-qPCR. Error bars are standard deviations of relative expression shown in the y axis.specific methyltransferase activity on H3K27, indicating that
JMJ serves as a subunit of the active PRC2 complex. Despite
its lack of KDM activity, JMJ modulates PRC2 function in
opposing ways. While promoting PRC2 recruitment to DNA
targets, JMJ inhibits methyltransferase activity of PRC2. Jmj/
ESCs show increased levels of H3K27me3 at target loci and fail
to activate lineage differentiation in a proper time course and
to the same extent as in wild-type cells. Thus, loss of Jmj shifts
the balance of pluripotency toward maintenance of the ESC
phenotype and compromises differentiation (Figure 7). These
consequences of JMJ loss establish its critical functions in
modulating H3K27me3 levels and orchestrating developmental1310 Cell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc.transitions. Our study reveals a new dimension in the dynamic
epigenetic regulation of gene expression.
JMJ Interacts with PRC2
Both JMJ and RBP2 belong to the JARID family. It was reported
previously that RBP2 interacts with PRC2 to maintain transcrip-
tional repression by coordinating H3K4me3 demethylation
and H3K27 methylation (Pasini et al., 2008). However, we have
not been able to confirm the association of RBP2 with PRC2
in ESCs. Sequencing of PRC2 protein complexes failed to
reveal RBP2-derived peptides (Tables S1–S4), and RBP2 did
not precipitate with EZH2 and SUZ12 (Figures 1H and S1).
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Figure 7. A Model for the Interplay between JMJ and PRC2 in Regu-
lating ESC Pluripotency
(A) In wild-type ESC, the inhibitory role of JMJ on PRC2 activity disfavors
formation of H3K27me3 and may facilitate attacks by opposing enzyme or
factors, such as UTX, JMJD3, and MLLs, resulting in transient H3K27me3
demethylation and a permissive chromatin structure for transcription. Para-
doxically, the positive role of JMJ in promoting PRC2 binding may redirect
PRC2 to chromatin to establish the H3K27me3 mark. Dynamic control of the
H3K27me3 mark defines the fine balance between the maintenance of the
ESC state and differentiation capacity and is required for rapid relief of repres-
sion and subsequent gene activation upon differentiation signals.
(B) In Jmj/ ESCs, H3K27me3 may be more rigidly positioned at target loci.
The balance tips toward maintenance of the stem cell phenotype. Genes
marked and repressed by H3K27me3 become refractory to activation on
differentiation signals.Coimmunoprecipitation by anti-RBP2 antibodies did not capture
EZH2 (Q. Yan and W. Kaelin, personal communication). In addi-
tion, RBP2 was barely detected when RBP2 and PRC2 compo-
nents were reconstituted in vitro (Figure S1). RBP2 colocalizes
with H3K4me3 but not H3K27me3 in human promonocytic
U937 cells (Lopez-Bigas et al., 2008). Depletion of RBP2 does
not affect PRC2 binding to chromatin (Pasini et al., 2008).
Thus, we believe that JMJ but not RBP2 is the bona fide JARID
family protein interacting with PRC2 in ESCs. However, other
JMJ-like, Jumonji family proteins may associate with PRC2 in
other developmental contexts. For instance, FBXL10 (KDM2B),
which is found to interact with EZH2 in 293T cells, promotesCH3K4me3 and H3K36me2 demethylation but facilitates PRC2
binding and H3K27me3 formation at the Ink4a/Arf locus (Tzatsos
et al., 2009).
PRC2 regulates multiple aspects of stem cell proliferation and
differentiation and is overexpressed in diverse cancers. Consid-
ering that the association of JMJ and PRC2 is not unique to
pluripotent ESCs, we speculate that JMJ may modulate PRC2
functions in other stem cells. As a portion of PRC2 appears
free of JMJ, it will be of interest to determine how the interaction
is regulated. We find that JMJ is highly prone to protein degrada-
tion during isolation of nuclear extracts (X.S. and S.H.O., unpub-
lished data). Regulation of JMJ stability through posttranslational
modification or by other protein factors may be a possible means
to modulate its function.
JMJ Regulates PRC2 Activity
Cooperation between SET domain-containing KMTs and
Jumonji family KDMs appears to be a consistent theme in
epigenetic regulation of transcription. The association of the
H3K27me2/3 demethylases UTX and JMJD3 with the H3K4
methyltransferase complexes (MLLs) provides an example of
coupling removal of a repressive mark with establishment of an
active mark (De Santa et al., 2007; Issaeva et al., 2007; Lee
et al., 2007). JMJ promotes chromatin targeting of PRC2,
whereas it inhibits the enzymatic activity of PRC2. This interplay
reveals a mechanism by which an epigenetic modifier regulates
gene expression by modulating its interacting KMT.
Despite compromised recruitment of PRC2 in Jmj/ ESCs,
the level of H3K27me3 on PRC2 target loci is paradoxically
increased. ChIP analyses of PRC2 and the H3K27me3 mark
may reflect different kinetics: transient recruitment of enzymatic
activity versus steady-state levels of a modification, respec-
tively. H3K27me3 occupancy on chromatin integrates PRC2
binding and activity, whereas PRC2 association on chromatin
is a snapshot of protein binding. With respect to H3K27me3
levels, our model suggests that increased activity of PRC2
gained by loss of JMJ inhibition appears to outweigh the dimin-
ished recruitment of PRC2 to chromatin in Jmj/ ESCs. Alter-
nately, loss of JMJ allows other modifiers to interact with and
modulate PRC2. For example, sequence analysis implies that
JMJ-containing PRC2 and MTF2-containing PRC2 may be
distinct protein complexes. Interestingly, PCL1, a homolog of
MTF2, in fly and mammals is required to generate high levels
of H3K27me3 at PcG target sites by directly stimulating PRC2
activity and possibly stabilizing PRC2 binding to chromatin
(Cao et al., 2008; Nekrasov et al., 2007; Sarma et al., 2008; Savla
et al., 2008). Loss of JMJ may augment MTF2 binding to PRC2,
hence increasing PRC2 activity and H3K27me3 levels in vivo. In
addition, we cannot rule out a possible role of EZH1 in establish-
ing high levels of H3K27me3 in Jmj/ ESCs. Despite decreased
chromatin association of SUZ12 in Ezh2/ ESCs, H3K27me3
levels on a subset of developmental genes are paradoxically
upregulated due to the noncanonical EZH1-containing PRC2
(Shen et al., 2008). Whether JMJ regulates EZH1-PRC2 activity
awaits further analysis.
Of 27 Jumonji family proteins in the human genome, only 15
have been reported to contain demethylase activity (Cloos
et al., 2008). Many Jumonji family proteins, including Hairlessell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc. 1311
(HR), PHF2, and Epe1, lack demethylase activity but remain
important in development. For example, HR is a transcriptional
corepressor essential for hair growth, but how HR regulates
the balance of proliferation and differentiation in epidermis cells
is elusive (Zarach et al., 2004). JMJ function within the PRC2
complex may provide a paradigm for regulation of KMT activity
by other enzymatically inactive Jumonji family proteins.
JMJ in Stem Cell Differentiation and Development
Similar toEzh2andEed,Jmj serves an important role in regulating
ESC differentiation. However, Jmj/ ESCs exhibit a distinct
differentiation time course from Ezh2/ and Eed/ cells.
Whereas Jmj/ cells show abnormal, prolonged activation of
primitive ectoderm and delayed entrance into mesoendoderm,
Ezh2/ and Eed/ cells initiate but fail to sustain primitive ecto-
derm and mesoendoderm. These phenotypic differences may
reflect intrinsic differences in how the H3K27me3 level at specific
target genes is altered in these cells. Jmj/ mutants contain
excessive H3K27me3 at targets, which may lead to augmented
repression and prevent efficient gene activation required for
differentiation. On the contrary, a global decrease or absence
of H3K27me3 in Ezh2/ and Eed/ cells may facilitate initial
lineage induction but fail to orchestrate a normal sequence of
events and epigenetically establish new cell fates that require
de novo establishment of H3K27me3 on chromatin. Despite
compromised and delayed differentiation of Jmj/ ESCs in
culture, Jmj-null mouse embryos gastrulate and form three
germ layers, suggesting that additional compensatory mecha-
nisms exist in vivo.
JMJ has been implicated in regulating development and
differentiation. In Drosophila, Jmj is required for metamorphosis
(Sasai et al., 2007). Jmj loss results in a delay of pupation and
lethality at larval and pupal stages. In mouse, Jmj/ embryos
show hyperproliferating cardiac and neural progenitor cells but
lack differentiating and mature cardiac myocytes and postmitotic
neurons (Jung et al., 2005; Takeuchi et al., 2006). Jmj/ hepato-
cytes proliferate normally but fail to differentiate and mature
in vivo and in vitro. Taken together with our findings, these obser-
vations support a critical role for JMJ in promoting stem/progen-
itor cell differentiation and mediating cell fate transitions.
Fine-Tuning of H3K27me3 in ESC Pluripotency
The role of JMJ in execution of pluripotency is consistent with
JMJ as a common target of multiple (>5) pluripotency transcrip-
tion factors (Chen et al., 2008; Kim et al., 2008; Zhou et al., 2007).
The expression of JMJ is robust in ESCs and induced pluripotent
stem (iPS) cells (Ambrosi et al., 2007; Mikkelsen et al., 2008;
Walker et al., 2007) and falls abruptly on differentiation. Levels
of EED, EZH2, and SUZ12 also decrease on differentiation
(Kuzmichev et al., 2005; Pasini et al., 2007). This series of events
presumably permits access of active KDMs to remove the
repressive H3K27me3 mark and facilitates rapid switching of
expression states in response to differentiation signals.
Global low-level transcriptional activity is a hallmark of the
ESC genome and is necessary for maintenance of the pluripotent
state (Efroni et al., 2008). It remains obscure how tissue-specific
genes are kept at a low-level expression state in ESCs and are
readily activated upon differentiation signals. The interplay1312 Cell 139, 1303–1314, December 24, 2009 ª2009 Elsevier Inc.between PRC2 and JMJ, which enables fine-tuning, rather
than on-off control, of methylation states on H3K27, provides
a mechanism for preserving expression plasticity.
In wild-type ESCs, the inhibitory role of JMJ on PRC2 activity
disfavors formation of H3K27me3 and may facilitate attacks by
opposing enzymes or factors, such as UTX, JMJD3, and MLLs,
resulting in transient H3K27me3 demethylation and a permissive
chromatin structure for transcription (Figure 7). On the other
hand, the positive role of JMJ in PRC2 recruitment may redirect
PRC2 to chromatin to establish the H3K27me3 mark. Thus, at
steady state the distribution of H3K27me3 at target sites reflects
a dynamic equilibrium controlled by JMJ and PRC2 and likely
influenced by UTX, MLLs, and other factors. Dynamic modulation
of H3K27me3 levels allows rapid reprogramming of the epige-
nome upon developmental or environmental signals and facili-
tates rapid relief of repression and subsequent gene activation.
In Jmj/ ESCs, H3K27me3 may be more rigidly positioned at
target loci. Imposition of static H3K27me3 modification may
convert a repressive, low expression state, with inherent plas-
ticity that permits transcriptional activation during differentiation,
to an ‘‘off’’ state. Developmental genes marked by H3K27me3
may become refractory to gene activation in the absence of
JMJ. As the balance in Jmj/ cells tips toward maintenance of
stem cell identity, these cells exhibit delayed and compromised
activation of a differentiation program in response to develop-
mental signals.
Dynamic control of NANOG, a key pluripotency regulator,
provides another example of the fine balance between
self-renewal and differentiation. Transitory downregulation of
NANOG mediated by TCF3 predisposes ESCs to differentiation
but does not mark commitment, while re-expression of NANOG
reverses precocious commitment and re-establishes the ESC
state (Chambers et al., 2007; Cole et al., 2008). TCF3 deletion,
or NANOG overexpression, renders ESCs refractory to differen-
tiation. Thus, the balance between maintenance of stem cell
identity and preservation of differentiation capability lies at the
heart of pluripotency.
Because reduced or excessive H3K27me3 modification
appears equally detrimental to gene regulation during cell fate
switches, our finding that JMJ modulates PRC2 functions and
ESC differentiation further supports the importance of chromatin
dynamics for early lineage decisions.
EXPERIMENTAL PROCEDURES
Cells and Culture
Mouse ESCs expressing bfEED, bfEZH1, and bfEZH2 have been described
previously (Shen et al., 2008). ESCs expressing bfJMJ or bfMTF2 were gener-
ated by introducing cDNA expressing biotin- and FLAG-tagged JMJ or MTF2
into J1 ESCs expressing bacterial biotin ligase birA, and stable clones were
selected by puromycin. Jmjfl/fl ESCs were isolated from mouse blastocysts
with the same genotype and treated with GFPCre (Gagneten et al., 1997) to
establish Jmj/ ESCs. Ezh2/ and Eed/ ESCs were described previously
(Montgomery et al., 2005; Shen et al., 2008). ESC culture and differentiation
were described previously (Shen et al., 2008).
Gel-Filtration Chromatography, Affinity Purification,
Coimmunoprecipitation, and Mass Spectrometry
These procedures were performed as described (Shen et al., 2008; Wang
et al., 2006). Details and antibodies are described in the Supplemental Data.
ChIP and BioChIP Analysis
Antibody-mediated ChIP or streptavidin-mediated bioChIP were performed as
described previously (Shen et al., 2008). ChIP-chip analyses of endogenous
JMJ, EZH2, and SUZ12 were performed on Affymetrix mouse promoter tiling
arrays. BioChIP-chip of bfJMJ was performed on Affymetrix mouse tiling 2.0R
array sets. Model-based analysis of tiling array (MAT) (Johnson et al., 2006)
was used to predict and map significant peaks (p < 1e-7) to the genome based
on mouse mm8 genome assembly. For ChIP and quantitative qPCR analysis,
DNA levels at various chromatin loci were first normalized to an internal control
region located in the first intron of Actb. Relative enrichments were calculated
by dividing the normalized level of ChIP DNA to that of input DNA at corre-
sponding locus. Error bars represent standard deviations of relative enrich-
ments from at least three biological replicates of ChIP. Primers were listed
previously (Shen et al., 2008).
Microarray Expression Profiling and RNA Analysis
Total RNA from undifferentiated (day 0) and differentiated ESCs (days 2, 4, 6,
and 8) was isolated by Trizol (Invitrogen), reversely transcribed by SuperScript
III (Invitrogen), labeled, and hybridized onto Affymetrix mouse genome 430 2.0
arrays. The GenePattern software was used for processing raw data and
GSEA (Reich et al., 2006). Heatmap comparison was generated by dChip
(Li and Wong, 2001). Gene ontology (GO) analysis was performed by DAVID
tools (Dennis et al., 2003). For individual RNA transcripts analysis, gene
expression was normalized to GADPH. Error bars represent standard devia-
tions of mean expression based on at least three cell and RNA isolations.
Primers sequences are listed in the Supplemental Data.
Baculoviral Expression and Protein Purification
Recombinant PRC2 was described previously (Shen et al., 2008). FLAG-
tagged JMJ and the dJc mutant were expressed by the Bac-to-Bac system
(Invitrogen) and purified as previously described (Shen et al., 2008).
Histone Methyltransferase Assay
Histone methyltransferase assays were performed as described previously
(Shen et al., 2008). Crude oligonucleosomes (S2 chromatin fraction) were iso-
lated from HeLa cells as described (Umlauf et al., 2004). Recombinant histones
including H3 (#31207), H3Kc9me3 (#31213), and H3Kc27me1/2/3 (#31214,
#31215, #31216) were from Active Motif. MLA histone octamers and nucleo-
somes were prepared as described (Simon et al., 2007). About 5 mg of native
nucleosomes from HeLa cells, 1 mg of recombinant histones, 0.5 mg of MLA
octamers or nucleosomes were used as substrates per reaction. Bovine serum
albumin (BSA, Sigma) was used as a negative control for the assays.
ACCESSION NUMBERS
Microarray data are available in the Gene Expression Omnibus (GEO) data-
base under accession number GSE19169.
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Supplemental Data include Supplemental Experimental Procedures, 6 figures,
and 14 tables and can be found with this article online at http://www.cell.com/
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